PHP
ANIP icon

Parkman Healthcare Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Parkman Healthcare Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Sell
202,907
-77,668
-28% -$6.23M 1.72% 23
2026
Q1 		$21.6M Buy
280,575
+135,575
+94% +$10.6M 2.23% 14
2025
Q4 		$11.4M Buy
+145,000
New +$12.6M 1.09% 35
2025
Q3 		– Sell
-128,478
Closed -$8.38M – 93
2025
Q2 		$8.38M Buy
128,478
+23,478
+22% +$1.53M 0.96% 36
2025
Q1 		$7.03M Buy
+105,000
New +$6.27M 0.83% 42
2023
Q4 		– Sell
-111,802
Closed -$6.49M – 93
2023
Q3 		$6.49M Sell
111,802
-62,675
-36% -$3.62M 1.19% 29
2023
Q2 		$9.39M Buy
174,477
+74,477
+74% +$3.3M 1.63% 21
2023
Q1 		$3.97M Sell
100,000
-26,874
-21% -$1.13M 0.86% 41
2022
Q4 		$5.1M Buy
126,874
+8,933
+8% +$336K 1.36% 26
2022
Q3 		$3.79M Buy
117,941
+9,382
+9% +$321K 1.08% 31
2022
Q2 		$3.22M Buy
108,559
+648
+0.6% +$18.7K 1.19% 27
2022
Q1 		$3.03M Sell
107,911
-29,315
-21% -$1.09M 0.89% 39
2021
Q4 		$6.32M Buy
137,226
+51,880
+61% +$2.23M 1.4% 27
2021
Q3 		$2.8M Buy
85,346
+30,000
+54% +$933K 0.71% 44
2021
Q2 		$1.94M Buy
+55,346
New +$1.88M 0.42% 60

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkman Healthcare Partners's ANIP Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its ANI Pharmaceuticals (ANIP) stake by 28% in Q2 2026, selling an estimated $6.23M and leaving 202,907 shares worth $16.8M. The position accounts for 1.72% of the portfolio, ranked #23.

Parkman Healthcare Partners first reported a position in ANIP in Q2 2021 and has held it in 15 quarters since. The position peaked at $21.6M in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Parkman Healthcare Partners held 202,907 shares of ANI Pharmaceuticals worth $16.8M as of Q2 2026.
  • Parkman Healthcare Partners sold 77,668 ANI Pharmaceuticals shares in Q2 2026, an estimated $6.23M.
  • ANI Pharmaceuticals made up 1.72% of Parkman Healthcare Partners's portfolio in Q2 2026, its #23 holding.
  • Parkman Healthcare Partners first reported a position in ANI Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • Parkman Healthcare Partners's ANI Pharmaceuticals position peaked at $21.6M in Q1 2026.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.